欧盟法规
C&L通报上下游产品
2-(Trichloromethyl)-1,8-naphthyridine (E)-2-styryl-1,8-naphthyridine 2-methyl-[1,8]naphthyridine (E)-4-(dimethylamino)but-3-en-2-one methyl 1,8-naphthyridine-2-carboxylate [1,8]naphthyridine-2-carboxylic acid [4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-amide 📜2-(三氯甲基)-1,8-二氮杂萘置于磷酸体系中,化学反应 3.0H,反应生成1,8-萘啶-2-甲酸
参考文献:Functionalization Of 2-Methyl-And 2,7-Dimethyl-1,8-Naphthyridine
标题:Functionalization Of 2-Methyl-And 2,7-Dimethyl-1,8-Naphthyridine
摘要:
Doi:10.1021/jo00296A051
海关参考信息
- 2905110000-甲醇
2912110000-甲醛
2915110000-甲酸
2933310010-吡啶 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2008187575-A1
优先权日:2004-08-27
标题:Pyrimidine Derivatives
发明人:KLEBL BERT; BAUMANN MATTHIAS; HOPPE EDMUND; BREHMER DIRK; DAUB HENRIK; KERI GYORGY; VARGA ZOLTAN; MAROSFALVI JENO; ORFI LASZLO
权利人:KLEBL BERT; BAUMANN MATTHIAS; HOPPE EDMUND; BREHMER DIRK; DAUB HENRIK; KERI GYORGY; VARGA ZOLTAN; MAROSFALVI JENO; ORFI LASZLO
摘要:The present invention relates to pyrimidine derivatives, methods for their synthesis, and the use of said pyrimidine derivatives as pharmaceutically active agents, especially for the prophylaxis and/or treatment of cell proliferation disorders, cancer, leukemia, erectile dysfunction, cardiovascular diseases and disorders, inflammatory diseases, transplant rejection, immunological diseases, neuroimmunological diseases, autoimmune diseases, infective diseases including opportunistic infections, prion diseases and/or neuro-degeneration. Furthermore, the present invention relates to pharmaceutical compositions containing at least one pyrimidine derivative and/or pharmaceutically acceptable salts thereof as an active ingredient together with at least one pharmaceutically acceptable carrier, excipient or diluents as well as to methods for prophylaxis and/or treatment of the above-mentioned diseases and disorders.
专利号:RU-2120940-C1
优先权日:1994-06-16
标题:Derivatives of quinoline- or naphthyridine carboxylic acid and methods of their synthesis
专利号:NO-318910-B1
优先权日:1998-12-23
标 题:Protease inhibitors, method of synthesis and use thereof, and pharmaceutical composition